ASP Isotopes lists on the JSE as its South African expansion continues

ASP Isotopes (ASPI), the Nasdaq-listed isotopes enrichment company that has most of its team operating in South Africa, and which is acquiring Renergen, listed on the JSE on Wednesday.

- EDWARD WEST

Just after midday Wednesday, the share price on the JSE represented an a8) premium to the $10.47 share price on the Nasdaq at the close of trade Tuesday - a trader said the volumes were thin, but there was definitely demand for the shares.

“While our capital footprint has expanded into the US and Europe, the core of our company is rooted in South Africa. With most of our team and operational assets based locally... listing on the JSE is not just a strategic move; it isa tribute to the nation which has world-class talent and institutional knowledge in all our core competencies,” said ASPI chairman and CEO Paul Mann.

The company develops technology and processes to enrich isotopes that can be used in the medical, semiconductor, and green energy (nuclear) industries, technology that has been born out of years of research and development, originally in South Africa.